课题基金 / 基金详情

Development of molecular tools for bifidobacterium species

Development of molecular tools for bifidobacterium species
双歧杆菌分子工具的开发
批准号:
23038-2009
负责人:
Lee, Byong
金额:
$2.26万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-01-01 至 2011-12-31

项目摘要

项目成果

Lee, Byong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Probiotic and prebiotic products as "quality of life and managing biological resources" are on the market in the forms of milk based drinks, yogurts and capsules. Intake of probiotic bacteria is associated with beneficial health benefits to the human and animal hosts, but current understanding of how the bacteria actually illicit these effects is not very good. Although the genetics and molecular tools of more common dairy lactic bacteria like Lactococcus and Lactobacillus exist, knowledge is lacking behind with closely related Bifidobacterium genus, which is phylogenetically and physiologically (bifidus shunt) distinct. After the molecular tools and mechanisms are elucidated, a more rational approach to the therapeutic use of probiotics could be possible. The current focus of my research program is centered on the hypothesis that one can study fundamental scientific knowledge and improve the performance of probiotic strain by genetic manipulation of its expression of certain proteins. As genetic tools become available for bifidobacteria, more work can be done on understanding their physiology and metabolic activities important for survival in food as well as for understanding their beneficial effects in the gastrointestinal system. The short term objectives are to (1) develop food grade cloning and expression systems, (2) construct new over-expression systems for production of a heterologous protein like bile salt hydrolase (BSH) to validate BSH hypothesis for cholesterol lowering effect of Bifidoabcterium lactis strains (BSH mutant, native and over-expressed) in hens and mice models, and 3) demonstrate the hypothesis that one can improve the performance of probiotic strains by cloning the genes of interest in the respective BSH negative mutants. An air and acid tolerant industrial strain, Bifidobacterium lactis clearly identified as probiotic traits that currently used in probiotic yogurts and this presents a challenge as very little genetic expression work has been done. The concept of developing an innovative Bifidobacterium food-grade vector and expression system to advance our understanding of the metabolic activity, gene function, and expression is a novelty that will be useful for researcher and industries to evaluate the probiotic effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of molecular tools for bifidobacterium species
  • 批准号:
    23038-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.09万
  • 财政年份:
    2012
  • 负责人:
    Lee, Byong
  • 依托单位:
Development of molecular tools for bifidobacterium species
  • 批准号:
    23038-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.26万
  • 财政年份:
    2011
  • 负责人:
    Lee, Byong
  • 依托单位:
Development of molecular tools for bifidobacterium species
  • 批准号:
    23038-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.26万
  • 财政年份:
    2009
  • 负责人:
    Lee, Byong
  • 依托单位:
Overproduction of transgalactosyl lactases and galacto-oligosaccharides
  • 批准号:
    270308-2003
  • 项目类别:
    Strategic Projects - Group
  • 资助金额:
    $5.03万
  • 财政年份:
    2005
  • 负责人:
    Lee, Byong
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: